What is EUDA Health Holdings Ltd's earnings per share (EPS)?

EUDA Health Holdings Ltd (EUDA) reported diluted earnings per share of $-1.48 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

EUDA Health Holdings Ltd Financials

EUDA

Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows EUDA Health Holdings Ltd (EUDA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EUDA FY2024 2026-04-28

EUDA’s business is financed outside the income statement, with persistent cash burn and very weak short-term liquidity.

From FY2022 through FY2024, operating cash flow stayed negative while financing cash flow stayed positive, even though revenue hovered around $4.0M; the business has been funded externally rather than by its own operations. That dependence matters because FY2024 current assets of $763K covered only a small slice of current liabilities of $4.14M, making liquidity tighter than the revenue line suggests.

The problem is not simply a sales slump: FY2024 revenue was slightly above FY2023, yet gross margin compressed from 22.7% to 19.0%, so each sale contributed less before overhead. With only $762K of gross profit, fixed costs appear oversized for this revenue base.

Even after total liabilities fell from $8.79M in FY2023 to $4.27M in FY2024, the current ratio was still just 0.2x because most obligations remained short-term. Negative equity means the balance sheet still carries a capital deficit, so the smaller liability stack did not translate into financial flexibility.

Financial Health Signals

Financial Health Score 43/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of EUDA Health Holdings Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Altman Z-Score Distress

-43.53

EUDA Health Holdings Ltd scores -43.53, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($37.2M) relative to total liabilities ($6.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

EUDA Health Holdings Ltd passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.88x

For every $1 of reported earnings, EUDA Health Holdings Ltd generates $0.88 in operating cash flow (-$2.4M OCF vs -$2.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-10.8x

EUDA Health Holdings Ltd earns $-10.8 in operating income for every $1 of interest expense (-$2.5M vs $229K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.8M

YoY+70.0%

EUDA Health Holdings Ltd generated $6.8M in revenue in fiscal year 2025. This represents an increase of 70.0% from the prior year.

EBITDA

-$2.3M

YoY+86.7%

EUDA Health Holdings Ltd's EBITDA was -$2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 86.7% from the prior year.

Net Income

-$2.8M

YoY+81.9%

EUDA Health Holdings Ltd reported -$2.8M in net income in fiscal year 2025. This represents an increase of 81.9% from the prior year.

EPS (Diluted)

$-1.48

EUDA Health Holdings Ltd earned $-1.48 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

-$2.5M

YoY-17.5%

EUDA Health Holdings Ltd generated -$2.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 17.5% from the prior year.

Cash & Debt

$345K

YoY+45.3%

EUDA Health Holdings Ltd held $345K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

EUDA Health Holdings Ltd had 2M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

43.9%

YoY+24.9pp

EUDA Health Holdings Ltd's gross margin was 43.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 24.9 percentage points from the prior year.

Operating Margin

-36.3%

YoY+395.9pp

EUDA Health Holdings Ltd's operating margin was -36.3% in fiscal year 2025, reflecting core business profitability. This is up 395.9 percentage points from the prior year.

Net Margin

-40.6%

YoY+342.2pp

EUDA Health Holdings Ltd's net profit margin was -40.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 342.2 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$249

EUDA Health Holdings Ltd invested $249 in research and development in fiscal year 2025.

Share Buybacks

N/A

Capital Expenditures

$77K

YoY-20.2%

EUDA Health Holdings Ltd invested $77K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 20.2% from the prior year.

EUDA Income Statement

Metric	FY25	FY24	FY23	FY22	FY21
Revenue	$6.8M+70.0%	$4.0M+8.2%	$3.7M-1.5%	$3.8M-17.4%	$4.6M
Cost of Revenue	$3.8M+17.8%	$3.2M+13.4%	$2.9M-1.0%	$2.9M-12.5%	$3.3M
Gross Profit	$3.0M+292.7%	$762K-9.5%	$842K-3.2%	$870K-30.4%	$1.2M
R&D Expenses	$249	N/A	N/A	$17K-86.7%	$129K
SG&A Expenses	$4.1M+29.2%	$3.2M-24.8%	$4.3M-26.6%	$5.8M+293.9%	$1.5M
Operating Income	-$2.5M+85.7%	-$17.3M-337.6%	-$4.0M+67.6%	-$12.2M-2082.0%	-$560K
Interest Expense	$229K+409.3%	$45K+93.3%	$23K	N/A	N/A
Income Tax	$42K+1057.6%	-$4K	N/A	-$21K-144.7%	$46K
Net Income	-$2.8M+81.9%	-$15.4M-53.0%	-$10.0M+59.7%	-$24.9M-2977.3%	$865K
EPS (Diluted)	$-1.48	$-9.46-7.9%	$-8.77-323.7%	$-2.07-2400.0%	$0.09

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$1.7M	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$1.3M	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	$404K	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$2.0M	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	-$2.0M-562.6%	-$298K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	$985	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	-$2.4M-1301.2%	$201K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	$-0.12	N/A

EUDA Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21
Total Assets	$1.7M+1.1%	$1.7M+29.6%	$1.3M-94.9%	$25.6M+220.4%	$8.0M
Current Assets	$1.0M+36.2%	$763K+5.5%	$723K-97.1%	$25.0M+475.0%	$4.4M
Cash & Equivalents	$345K+45.3%	$238K+25.7%	$189K+228.5%	$58K-69.7%	$190K
Inventory	$3K-97.8%	$129K	N/A	N/A	N/A
Accounts Receivable	$243K+66.0%	$146K-38.4%	$237K+23.1%	$193K-89.3%	$1.8M
Goodwill	N/A	$0	$0	N/A	$993K
Total Liabilities	$6.0M+40.1%	$4.3M-51.4%	$8.8M-69.8%	$29.1M+293.8%	$7.4M
Current Liabilities	$5.8M+40.9%	$4.1M-52.5%	$8.7M-70.1%	$29.1M+298.0%	$7.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A
Total Equity	-$4.3M-66.7%	-$2.6M+66.0%	-$7.5M-113.0%	-$3.5M-775.4%	$521K
Retained Earnings	-$52.9M-5.5%	-$50.1M-44.2%	-$34.7M-40.6%	-$24.7M-13799.0%	$180K

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Total Assets	$1.7M-19.1%	$2.1M+25.0%	$1.7M-16.3%	$2.0M+54.7%	$1.3M	N/A	$25.5M-70.8%	$87.3M
Current Assets	$1.0M-20.4%	$1.3M+71.3%	$763K-27.8%	$1.1M+46.0%	$723K	N/A	$24.8M-71.6%	$87.3M
Cash & Equivalents	$345K+95.5%	$177K-25.7%	$238K-36.8%	$376K+99.0%	$189K	N/A	$837K+214.9%	$266K
Inventory	$3K-97.6%	$117K-9.4%	$129K	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$243K-43.1%	$427K+191.9%	$146K-17.4%	$177K-25.5%	$237K	N/A	$1.6M	N/A
Goodwill	N/A	N/A	$0	N/A	$0	N/A	N/A	N/A
Total Liabilities	$6.0M+2.3%	$5.8M+37.0%	$4.3M-46.9%	$8.0M-8.6%	$8.8M	N/A	$31.4M-65.6%	$91.3M
Current Liabilities	$5.8M+2.2%	$5.7M+37.8%	$4.1M-47.5%	$7.9M-9.6%	$8.7M	N/A	$31.3M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$4.3M-14.7%	-$3.7M-45.3%	-$2.6M+57.6%	-$6.0M+19.7%	-$7.5M-25.5%	-$6.0M-0.4%	-$6.0M-48.0%	-$4.0M
Retained Earnings	-$52.9M-3.1%	-$51.3M-2.4%	-$50.1M+2.9%	-$51.6M-48.4%	-$34.7M	N/A	-$27.1M-574.3%	-$4.0M

EUDA Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	-$2.4M-19.3%	-$2.0M+30.3%	-$2.9M-91.1%	-$1.5M-443.9%	$444K
Capital Expenditures	$77K-20.2%	$97K	N/A	$18K+1547.3%	$1K
Free Cash Flow	-$2.5M-17.5%	-$2.1M	N/A	-$1.5M-448.9%	$443K
Investing Cash Flow	-$104K+29.3%	-$148K	N/A	-$268K+24.7%	-$356K
Financing Cash Flow	$2.6M+9.7%	$2.3M-1.2%	$2.4M-5.5%	$2.5M+1578.2%	-$168K
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	-$1.7M-263.2%	-$470K-279.6%	-$124K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	$1.2M+125.8%	$525K+167.9%	$196K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

EUDA Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21
Gross Margin	43.9%+24.9pp	19.0%-3.7pp	22.7%-0.4pp	23.1%-4.3pp	27.4%
Operating Margin	-36.3%+395.9pp	-432.2%-325.3pp	-106.9%+217.7pp	-324.6%-312.3pp	-12.3%
Net Margin	-40.6%+342.2pp	-382.9%-112.0pp	-270.9%+390.2pp	-661.1%-680.0pp	19.0%
Return on Equity	N/A	N/A	N/A	N/A	165.9%
Return on Assets	-161.5%+743.0pp	-904.5%-138.4pp	-766.1%-669.0pp	-97.1%-107.9pp	10.8%
Current Ratio	0.180.0	0.18+0.1	0.08-0.8	0.86+0.3	0.59
Debt-to-Equity	-1.41+0.3	-1.67-0.5	-1.17+7.1	-8.28-22.5	14.20
FCF Margin	-36.7%+16.4pp	-53.1%	N/A	-41.0%-50.7pp	9.7%

Metric	Q4'25	Q2'25	Q4'24	Q2'24	Q4'23	Q2'23	Q1'23	Q4'22
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	23.8%	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	-116.4%	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	-142.1%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	-9.5%-9.7pp	0.2%
Current Ratio	0.18-0.1	0.23+0.0	0.18+0.1	0.13+0.1	0.08	N/A	0.79	N/A
Debt-to-Equity	-1.41+0.2	-1.58+0.1	-1.67-0.3	-1.33-0.2	-1.17	N/A	-5.28+17.4	-22.70
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$4.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.18), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Rafael Holdings RFL

$118.0M

CHG

$34.5M

Ohmyhome Limited OMH

$8.8M

Fangdd Network Group Ltd. DUO

$24.4M

American Strategic Investment Co. NYC

$24.8M

Frequently Asked Questions

What is EUDA Health Holdings Ltd's annual revenue?

EUDA Health Holdings Ltd (EUDA) reported $6.8M in total revenue for fiscal year 2025. This represents a 70.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is EUDA Health Holdings Ltd's revenue growing?

EUDA Health Holdings Ltd (EUDA) revenue grew by 70% year-over-year, from $4.0M to $6.8M in fiscal year 2025.

Is EUDA Health Holdings Ltd profitable?

No, EUDA Health Holdings Ltd (EUDA) reported a net income of -$2.8M in fiscal year 2025, with a net profit margin of -40.6%.

What is EUDA Health Holdings Ltd's EBITDA?

EUDA Health Holdings Ltd (EUDA) had EBITDA of -$2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is EUDA Health Holdings Ltd's gross margin?

EUDA Health Holdings Ltd (EUDA) had a gross margin of 43.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is EUDA Health Holdings Ltd's operating margin?

EUDA Health Holdings Ltd (EUDA) had an operating margin of -36.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is EUDA Health Holdings Ltd's net profit margin?

EUDA Health Holdings Ltd (EUDA) had a net profit margin of -40.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is EUDA Health Holdings Ltd's free cash flow?

EUDA Health Holdings Ltd (EUDA) generated -$2.5M in free cash flow during fiscal year 2025. This represents a -17.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is EUDA Health Holdings Ltd's operating cash flow?

EUDA Health Holdings Ltd (EUDA) generated -$2.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are EUDA Health Holdings Ltd's total assets?

EUDA Health Holdings Ltd (EUDA) had $1.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are EUDA Health Holdings Ltd's capital expenditures?

EUDA Health Holdings Ltd (EUDA) invested $77K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does EUDA Health Holdings Ltd spend on research and development?

EUDA Health Holdings Ltd (EUDA) invested $249 in research and development during fiscal year 2025.

How many shares does EUDA Health Holdings Ltd have outstanding?

EUDA Health Holdings Ltd (EUDA) had 2M shares outstanding as of fiscal year 2025.

What is EUDA Health Holdings Ltd's current ratio?

EUDA Health Holdings Ltd (EUDA) had a current ratio of 0.18 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is EUDA Health Holdings Ltd's debt-to-equity ratio?

EUDA Health Holdings Ltd (EUDA) had a debt-to-equity ratio of -1.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is EUDA Health Holdings Ltd's return on assets (ROA)?

EUDA Health Holdings Ltd (EUDA) had a return on assets of -161.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is EUDA Health Holdings Ltd's cash runway?

Based on fiscal year 2025 data, EUDA Health Holdings Ltd (EUDA) had $345K in cash against an annual operating cash burn of $2.4M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is EUDA Health Holdings Ltd's debt-to-equity ratio negative or unusual?

EUDA Health Holdings Ltd (EUDA) has negative shareholder equity of -$4.3M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is EUDA Health Holdings Ltd's Altman Z-Score?

EUDA Health Holdings Ltd (EUDA) has an Altman Z-Score of -43.53, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is EUDA Health Holdings Ltd's Piotroski F-Score?

EUDA Health Holdings Ltd (EUDA) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are EUDA Health Holdings Ltd's earnings high quality?

EUDA Health Holdings Ltd (EUDA) has an earnings quality ratio of 0.88x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can EUDA Health Holdings Ltd cover its interest payments?

EUDA Health Holdings Ltd (EUDA) has an interest coverage ratio of -10.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is EUDA Health Holdings Ltd?

EUDA Health Holdings Ltd (EUDA) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.